{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T03:48:51Z","timestamp":1781322531925,"version":"3.54.1"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T00:00:00Z","timestamp":1601337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Department of Biotechnology, Government of India"},{"DOI":"10.13039\/501100004837","name":"Spanish Ministry of Science and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000200","name":"United States Agency for International Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000200","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,6,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Targeting multiple key antigens that mediate distinct Plasmodium falciparum erythrocyte invasion pathways is an attractive approach for the development of blood-stage malaria vaccines. However, the challenge is to identify antigen cocktails that elicit potent strain-transcending parasite-neutralizing antibodies efficacious at low immunoglobulin G concentrations feasible to achieve through vaccination. Previous reports have screened inhibitory antibodies primarily against well adapted laboratory parasite clones. However, validation of the parasite-neutralizing efficacy against clinical isolates with minimal in vitro cultivation is equally significant to better ascertain their prospective in vivo potency.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We evaluated the parasite-neutralizing activity of different antibodies individually and in combinations against laboratory adapted clones and clinical isolates. Clinical isolates were collected from Central India and Mozambique, Africa, and characterized for their invasion properties and genetic diversity of invasion ligands.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>In our portfolio, we evaluated 25 triple antibody combinations and identified the MSP-Fu+CyRPA+RH5 antibody combination to elicit maximal parasite neutralization against P. falciparum clinical isolates with variable properties that underwent minimal in vitro cultivation.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The MSP-Fu+CyRPA+RH5 combination exhibited highly robust parasite neutralization against P. falciparum clones and clinical isolates, thus substantiating them as promising candidate antigens and establishing a proof of principle for the development of a combinatorial P. falciparum blood-stage malaria vaccine.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/infdis\/jiaa608","type":"journal-article","created":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T19:14:56Z","timestamp":1600974896000},"page":"1953-1964","source":"Crossref","is-referenced-by-count":10,"title":["Antibody Combinations Targeting the Essential Antigens CyRPA, RH5, and MSP-119 Potently Neutralize <i>Plasmodium falciparum<\/i> Clinical Isolates From India and Africa"],"prefix":"10.1093","volume":"223","author":[{"given":"Hina","family":"Singh","sequence":"first","affiliation":[{"name":"Laboratory of Malaria and Vaccine Research, School of Biotechnology, Jawaharlal Nehru University, New Delhi, India"},{"name":"Malaria Group, International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Yusuf","family":"Mian","sequence":"additional","affiliation":[{"name":"Laboratory of Malaria and Vaccine Research, School of Biotechnology, Jawaharlal Nehru University, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alok K","family":"Pandey","sequence":"additional","affiliation":[{"name":"Malaria Group, International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sri","family":"Krishna","sequence":"additional","affiliation":[{"name":"National Institute for Research in Tribal Health (NIRTH), Jabalpur, Madhya Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Anand","sequence":"additional","affiliation":[{"name":"Laboratory of Malaria and Vaccine Research, School of Biotechnology, Jawaharlal Nehru University, New Delhi, India"},{"name":"Malaria Group, International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K Sony","family":"Reddy","sequence":"additional","affiliation":[{"name":"Malaria Group, International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi, India"},{"name":"School of Biotechnology, Kalinga Institute of Industrial Technology (KIIT), Bhubaneswar, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Chaturvedi","sequence":"additional","affiliation":[{"name":"National Institute for Research in Tribal Health (NIRTH), Jabalpur, Madhya Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanndita","family":"Bahl","sequence":"additional","affiliation":[{"name":"Laboratory of Malaria and Vaccine Research, School of Biotechnology, Jawaharlal Nehru University, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nidhi","family":"Hans","sequence":"additional","affiliation":[{"name":"Malaria Group, International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man Mohan","family":"Shukla","sequence":"additional","affiliation":[{"name":"National Institute for Research in Tribal Health (NIRTH), Jabalpur, Madhya Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quique","family":"Bassat","sequence":"additional","affiliation":[{"name":"ISGlobal, Hospital Cl\u00ednic-Universitat de Barcelona, Barcelona, Spain"},{"name":"Centro de Investiga\u00e7\u00e3o em Sa\u00fade de Manhi\u00e7a (CISM), Maputo, Mozambique"},{"name":"ICREA, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Mayor","sequence":"additional","affiliation":[{"name":"ISGlobal, Hospital Cl\u00ednic-Universitat de Barcelona, Barcelona, Spain"},{"name":"Centro de Investiga\u00e7\u00e3o em Sa\u00fade de Manhi\u00e7a (CISM), Maputo, Mozambique"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazutoyo","family":"Miura","sequence":"additional","affiliation":[{"name":"Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praveen K","family":"Bharti","sequence":"additional","affiliation":[{"name":"National Institute for Research in Tribal Health (NIRTH), Jabalpur, Madhya Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Long","sequence":"additional","affiliation":[{"name":"Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeru","family":"Singh","sequence":"additional","affiliation":[{"name":"National Institute for Research in Tribal Health (NIRTH), Jabalpur, Madhya Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virander Singh","family":"Chauhan","sequence":"additional","affiliation":[{"name":"Malaria Group, International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Gaur","sequence":"additional","affiliation":[{"name":"Laboratory of Malaria and Vaccine Research, School of Biotechnology, Jawaharlal Nehru University, New Delhi, India"},{"name":"Malaria Group, International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,9,29]]},"reference":[{"key":"2021092900021703200_CIT0001","author":"World Health Organization (WHO)","year":"2019"},{"key":"2021092900021703200_CIT0002","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.ijpara.2004.10.010","article-title":"Parasite ligand-host receptor interactions during invasion of erythrocytes by Plasmodium merozoites","volume":"34","author":"Gaur","year":"2004","journal-title":"Int J Parasitol"},{"key":"2021092900021703200_CIT0003","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.cell.2006.02.006","article-title":"Invasion of red blood cells by malaria parasites","volume":"124","author":"Cowman","year":"2006","journal-title":"Cell"},{"key":"2021092900021703200_CIT0004","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/9781118493816.ch3","article-title":"Molecular basis of erythrocyte invasion by Plasmodium merozoites","volume-title":"Advances in Malaria Research","author":"Gaur","year":"2016"},{"key":"2021092900021703200_CIT0005","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/9781118493816.ch19","article-title":"Progress in development of malaria vaccines","volume-title":"Advances in Malaria Research","author":"Chitnis","year":"2016"},{"key":"2021092900021703200_CIT0006","doi-asserted-by":"crossref","first-page":"eaau1458","DOI":"10.1126\/scitranslmed.aau1458","article-title":"Challenges and strategies for developing efficacious and long-lasting malaria vaccines","volume":"11","author":"Beeson","year":"2019","journal-title":"Sci Transl Med"},{"key":"2021092900021703200_CIT0007","doi-asserted-by":"crossref","first-page":"e1000398","DOI":"10.1371\/journal.pmed.1000398","article-title":"A research agenda for malaria eradication: vaccines","volume":"8","author":"The malERA Consultative Group on Vaccines","year":"2011","journal-title":"PLoS Med"},{"key":"2021092900021703200_CIT0008","doi-asserted-by":"crossref","first-page":"e4708","DOI":"10.1371\/journal.pone.0004708","article-title":"Blood stage malaria vaccine eliciting high antigen-specific antibody concentrations confers no protection to young children in Western Kenya","volume":"4","author":"Ogutu","year":"2009","journal-title":"PLoS One"},{"key":"2021092900021703200_CIT0009","doi-asserted-by":"crossref","first-page":"e5254","DOI":"10.1371\/journal.pone.0005254","article-title":"Phase 1\/2a study of the malaria vaccine candidate apical membrane antigen-1 (AMA-1) administered in adjuvant system AS01B or AS02A","volume":"4","author":"Spring","year":"2009","journal-title":"PLoS One"},{"key":"2021092900021703200_CIT0010","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1128\/IAI.01107-12","article-title":"Identification of a potent combination of key Plasmodium falciparum merozoite antigens that elicit strain-transcending parasite-neutralizing antibodies","volume":"81","author":"Pandey","year":"2013","journal-title":"Infect Immun"},{"key":"2021092900021703200_CIT0011","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1128\/IAI.00970-13","article-title":"Bacterially expressed full-length recombinant Plasmodium falciparum RH5 protein binds erythrocytes and elicits potent strain-transcending parasite-neutralizing antibodies","volume":"82","author":"Reddy","year":"2014","journal-title":"Infect Immun"},{"key":"2021092900021703200_CIT0012","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/ncomms1615","article-title":"The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody","volume":"2","author":"Douglas","year":"2011","journal-title":"Nat Commun"},{"key":"2021092900021703200_CIT0013","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.3389\/fimmu.2019.01254","article-title":"Functional comparison of blood-stage Plasmodium falciparum malaria vaccine candidate antigens","volume":"10","author":"Illingworth","year":"2019","journal-title":"Front Immunol"},{"key":"2021092900021703200_CIT0014","first-page":"409","article-title":"Merozoite surface protein 1, immune evasion, and vaccines against asexual blood stage malaria","volume":"41","author":"Holder","year":"1999","journal-title":"Parassitologia"},{"key":"2021092900021703200_CIT0015","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1128\/IAI.72.3.1557-1567.2004","article-title":"Fine specificity of serum antibodies to Plasmodium falciparum merozoite surface protein, PfMSP-1(19), predicts protection from malaria infection and high-density parasitemia","volume":"72","author":"Okech","year":"2004","journal-title":"Infect Immun"},{"key":"2021092900021703200_CIT0016","doi-asserted-by":"crossref","first-page":"e0117820","DOI":"10.1371\/journal.pone.0117820","article-title":"Phase I clinical trial of a recombinant blood stage vaccine candidate for Plasmodium falciparum malaria based on MSP1 and EBA175","volume":"10","author":"Chitnis","year":"2015","journal-title":"PLoS One"},{"key":"2021092900021703200_CIT0017","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1128\/IAI.00427-09","article-title":"Plasmodium falciparum merozoite surface protein 1 (MSP-1)-MSP-3 chimeric protein: immunogenicity determined with human-compatible adjuvants and induction of protective immune response","volume":"78","author":"Mazumdar","year":"2010","journal-title":"Infect Immun"},{"key":"2021092900021703200_CIT0018","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1128\/CVI.00179-14","article-title":"Production and preclinical evaluation of Plasmodium falciparum MSP-119 and MSP-311 chimeric protein, PfMSP-Fu24","volume":"21","author":"Gupta","year":"2014","journal-title":"Clin Vaccine Immunol"},{"key":"2021092900021703200_CIT0019","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1182\/blood.V84.5.1594.1594","article-title":"Merozoite surface protein-3: a malaria protein inducing antibodies that promote Plasmodium falciparum killing by cooperation with blood monocytes","volume":"84","author":"Oeuvray","year":"1994","journal-title":"Blood"},{"key":"2021092900021703200_CIT0020","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1128\/CVI.00064-11","article-title":"Comparative immunogenicities of full-length Plasmodium falciparum merozoite surface protein 3 and a 24-kilodalton N-terminal fragment","volume":"18","author":"Imam","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"2021092900021703200_CIT0021","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1093\/emboj\/cdg096","article-title":"Phenotypic variation of Plasmodium falciparum merozoite proteins directs receptor targeting for invasion of human erythrocytes","volume":"22","author":"Duraisingh","year":"2003","journal-title":"EMBO J"},{"key":"2021092900021703200_CIT0022","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1365-2958.2004.04388.x","article-title":"Reticulocyte-binding protein homologue 1 is required for sialic acid-dependent invasion into human erythrocytes by Plasmodium falciparum","volume":"55","author":"Triglia","year":"2005","journal-title":"Mol Microbiol"},{"key":"2021092900021703200_CIT0023","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.molbiopara.2005.10.004","article-title":"Upregulation of expression of the reticulocyte homology gene 4 in the Plasmodium falciparum clone Dd2 is associated with a switch in the erythrocyte invasion pathway","volume":"145","author":"Gaur","year":"2006","journal-title":"Mol Biochem Parasitol"},{"key":"2021092900021703200_CIT0024","doi-asserted-by":"crossref","first-page":"17789","DOI":"10.1073\/pnas.0708772104","article-title":"Recombinant Plasmodium falciparum reticulocyte homology protein 4 binds to erythrocytes and blocks invasion","volume":"104","author":"Gaur","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2021092900021703200_CIT0025","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.chom.2008.06.001","article-title":"Erythrocyte binding protein PfRH5 polymorphisms determine species-specific pathways of Plasmodium falciparum invasion","volume":"4","author":"Hayton","year":"2008","journal-title":"Cell Host Microbe"},{"key":"2021092900021703200_CIT0026","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ijpara.2008.10.006","article-title":"Reticulocyte-binding protein homologue 5 - an essential adhesin involved in invasion of human erythrocytes by Plasmodium falciparum","volume":"39","author":"Baum","year":"2009","journal-title":"Int J Parasitol"},{"key":"2021092900021703200_CIT0027","doi-asserted-by":"crossref","first-page":"e1004670","DOI":"10.1371\/journal.ppat.1004670","article-title":"Revealing the sequence and resulting cellular morphology of receptor-ligand interactions during Plasmodium falciparum invasion of erythrocytes","volume":"11","author":"Weiss","year":"2015","journal-title":"PLoS Pathog"},{"key":"2021092900021703200_CIT0028","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.vaccine.2012.10.106","article-title":"A full-length recombinant Plasmodium falciparum PfRH5 protein induces inhibitory antibodies that are effective across common PfRH5 genetic variants","volume":"31","author":"Bustamante","year":"2013","journal-title":"Vaccine"},{"key":"2021092900021703200_CIT0029","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.chom.2014.11.017","article-title":"A PfRH5-based vaccine is efficacious against heterologous strain blood-stage Plasmodium falciparum infection in aotus monkeys","volume":"17","author":"Douglas","year":"2015","journal-title":"Cell Host Microbe"},{"key":"2021092900021703200_CIT0030","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.cell.2019.05.025","article-title":"Human antibodies that slow erythrocyte invasion potentiate malaria-neutralizing antibodies","volume":"178","author":"Alanine","year":"2019","journal-title":"Cell"},{"key":"2021092900021703200_CIT0031","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1073\/pnas.1415466112","article-title":"Multiprotein complex between the GPI-anchored CyRPA with PfRH5 and PfRipr is crucial for Plasmodium falciparum erythrocyte invasion","volume":"112","author":"Reddy","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2021092900021703200_CIT0032","doi-asserted-by":"crossref","first-page":"e1002199","DOI":"10.1371\/journal.ppat.1002199","article-title":"An EGF-like protein forms a complex with PfRh5 and is required for invasion of human erythrocytes by Plasmodium falciparum","volume":"7","author":"Chen","year":"2011","journal-title":"PLoS Pathog"},{"key":"2021092900021703200_CIT0033","doi-asserted-by":"crossref","first-page":"6225","DOI":"10.4049\/jimmunol.1103177","article-title":"Passive immunoprotection of Plasmodium falciparum-infected mice designates the CyRPA as candidate malaria vaccine antigen","volume":"188","author":"Dreyer","year":"2012","journal-title":"J Immunol"},{"key":"2021092900021703200_CIT0034","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.chom.2016.06.004","article-title":"Essential role of the PfRh5\/PfRipr\/CyRPA complex during Plasmodium falciparum invasion of erythrocytes","volume":"20","author":"Volz","year":"2016","journal-title":"Cell Host Microbe"},{"key":"2021092900021703200_CIT0035","doi-asserted-by":"crossref","first-page":"14333","DOI":"10.1038\/ncomms14333","article-title":"P113 is a merozoite surface protein that binds the N terminus of Plasmodium falciparum RH5","volume":"8","author":"Galaway","year":"2017","journal-title":"Nat Commun"},{"key":"2021092900021703200_CIT0036","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41541-020-0158-9","article-title":"Vaccination with virosomally formulated recombinant CyRPA elicits protective antibodies against Plasmodium falciparum parasites in preclinical in vitro and in vivo models","volume":"5","author":"Tamborrini","year":"2020","journal-title":"NPJ Vaccines"},{"key":"2021092900021703200_CIT0037","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1093\/cid\/cix837","article-title":"Identifying immune correlates of protection against Plasmodium falciparum through a novel approach to account for heterogeneity in malaria exposure","volume":"66","author":"Valmaseda","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2021092900021703200_CIT0038","doi-asserted-by":"crossref","first-page":"12045","DOI":"10.1073\/pnas.1702944114","article-title":"Synergistic malaria vaccine combinations identified by systematic antigen screening","volume":"114","author":"Bustamante","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2021092900021703200_CIT0039","doi-asserted-by":"crossref","first-page":"e1002991","DOI":"10.1371\/journal.ppat.1002991","article-title":"Enhancing blockade of Plasmodium falciparum erythrocyte invasion: assessing combinations of antibodies against PfRH5 and other merozoite antigens","volume":"8","author":"Williams","year":"2012","journal-title":"PLoS Pathog"},{"key":"2021092900021703200_CIT0040","doi-asserted-by":"crossref","first-page":"e73730","DOI":"10.1371\/journal.pone.0073730","article-title":"Dynamics of forest malaria transmission in Balaghat district, Madhya Pradesh, India","volume":"8","author":"Singh","year":"2013","journal-title":"PLoS One"},{"key":"2021092900021703200_CIT0041","doi-asserted-by":"crossref","first-page":"e19422","DOI":"10.1371\/journal.pone.0019422","article-title":"Association of severe malaria outcomes with platelet-mediated clumping and adhesion to a novel host receptor","volume":"6","author":"Mayor","year":"2011","journal-title":"PLoS One"},{"key":"2021092900021703200_CIT0042","doi-asserted-by":"crossref","first-page":"e17102","DOI":"10.1371\/journal.pone.0017102","article-title":"Plasmodium falciparum reticulocyte binding-like homologue protein 2 (PfRH2) is a key adhesive molecule involved in erythrocyte invasion","volume":"6","author":"Sahar","year":"2011","journal-title":"PLoS One"},{"key":"2021092900021703200_CIT0043","doi-asserted-by":"crossref","first-page":"e1732","DOI":"10.1371\/journal.pone.0001732","article-title":"Identification and characterization of a novel Plasmodium falciparum merozoite apical protein involved in erythrocyte binding and invasion","volume":"3","author":"Wickramarachchi","year":"2008","journal-title":"PLoS One"},{"key":"2021092900021703200_CIT0044","doi-asserted-by":"crossref","first-page":"795","DOI":"10.4049\/jimmunol.1300778","article-title":"Identification and prioritization of merozoite antigens as targets of protective human immunity to Plasmodium falciparum malaria for vaccine and biomarker development","volume":"191","author":"Richards","year":"2013","journal-title":"J Immunol"},{"key":"2021092900021703200_CIT0045","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1017\/S0031182017001949","article-title":"Mechanisms of naturally acquired immunity to P. falciparum and approaches to identify merozoite antigen targets","volume":"145","author":"Healer","year":"2018","journal-title":"Parasitology"},{"key":"2021092900021703200_CIT0046","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/nature13715","article-title":"Structure of malaria invasion protein RH5 with erythrocyte basigin and blocking antibodies","volume":"515","author":"Wright","year":"2014","journal-title":"Nature"},{"key":"2021092900021703200_CIT0047","doi-asserted-by":"crossref","first-page":"245","DOI":"10.4049\/jimmunol.1302045","article-title":"Neutralization of Plasmodium falciparum merozoites by antibodies against PfRH5","volume":"192","author":"Douglas","year":"2014","journal-title":"J Immunol"},{"key":"2021092900021703200_CIT0048","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/cmi.13030","article-title":"Neutralising antibodies block the function of Rh5\/Ripr\/CyRPA complex during invasion of Plasmodium falciparum into human erythrocytes","volume":"21","author":"Healer","year":"2019","journal-title":"Cell Microbiol"},{"key":"2021092900021703200_CIT0049","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7554\/eLife.21347","article-title":"Structural basis for inhibition of erythrocyte invasion by antibodies to Plasmodium falciparum protein CyRPA","volume":"6","author":"Chen","year":"2017","journal-title":"Elife"},{"key":"2021092900021703200_CIT0050","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1128\/IAI.05887-11","article-title":"Plasmodium falciparum 19-kilodalton merozoite surface protein 1 (MSP1)-specific antibodies that interfere with parasite growth in vitro can inhibit MSP1 processing, merozoite invasion, and intracellular parasite development","volume":"80","author":"Moss","year":"2012","journal-title":"Infect Immun"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiaa608\/34340849\/jiaa608.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/223\/11\/1953\/38488596\/jiaa608.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/223\/11\/1953\/38488596\/jiaa608.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T00:17:58Z","timestamp":1632874678000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/223\/11\/1953\/5912652"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,29]]},"references-count":50,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2020,9,29]]},"published-print":{"date-parts":[[2021,6,4]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiaa608","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,6,1]]},"published":{"date-parts":[[2020,9,29]]}}}